Literature DB >> 3688923

Muscle carnitine deficiency presenting as familial fatal cardiomyopathy.

A A Colin1, M Jaffe, Y Shapira, Z Ne'eman, A Gutman, S Korman.   

Abstract

Three siblings presented with fatal cardiomyopathy confirmed by electron microscopy, and normal serum but low muscle carnitine concentrations. A fourth had similar signs but remained asymptomatic. He was treated with carnitine orally which increased the concentration in muscle, though it remained below normal. Electron microscopic features were unchanged.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3688923      PMCID: PMC1778534          DOI: 10.1136/adc.62.11.1170

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy.

Authors:  M E Tripp; M L Katcher; H A Peters; E F Gilbert; S Arya; R J Hodach; A L Shug
Journal:  N Engl J Med       Date:  1981-08-13       Impact factor: 91.245

2.  Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome.

Authors:  A G Engel; C Angelini
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

3.  Nearly fatal muscle carnitine deficiency with full recovery after replacement therapy.

Authors:  L D Prockop; W K Engel; A L Shug
Journal:  Neurology       Date:  1983-12       Impact factor: 9.910

4.  Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome.

Authors:  P R Chapoy; C Angelini; W J Brown; J E Stiff; A L Shug; S D Cederbaum
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

Review 5.  Carnitine metabolism and deficiency syndromes.

Authors:  C J Rebouche; A G Engel
Journal:  Mayo Clin Proc       Date:  1983-08       Impact factor: 7.616

6.  Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport.

Authors:  L J Waber; D Valle; C Neill; S DiMauro; A Shug
Journal:  J Pediatr       Date:  1982-11       Impact factor: 4.406

  6 in total
  1 in total

1.  Serum carnitine levels in patients with homozygous beta thalassemia: a possible new role for carnitine?

Authors:  Vasileios Tsagris; Georgia Liapi-Adamidou
Journal:  Eur J Pediatr       Date:  2004-11-30       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.